Baidu Ventures has helped close a $31m series A round for Harvard-founded Sherlock Biosciences just over a month after the spinout launched with an initial $17.5m tranche.
Sherlock Biosciences, a US-based molecular diagnostics platform based on research at Harvard University, closed a $31m series A round on Tuesday following a $13.5m extension featuring Baidu Ventures, a corporate venturing arm of internet group Baidu.
Nonprofit group Open Philanthropy Project and VC firm Northpond Ventures also took part, alongside several unnamed investors.
Sherlock previously raised an initial $17.5m in series A funding from Open Philanthropy Project and unnamed investors in March 2019.
The spinout was…
